feed,title,long_url,short_url
BioRxiv,SARS-CoV-2 Subunit Virus-Like Vaccine Demonstrates High Safety Profile and Protective Efficacy: Preclinical Study,https://biorxiv.org/cgi/content/short/2022.05.18.492452v1?rss=1,https://bit.ly/3LlrACA
BioRxiv,Using unsupervised learning algorithms to identify essential genes associated with SARS-CoV-2 as potential therapeutic targets for COVID-19,https://biorxiv.org/cgi/content/short/2022.05.18.492443v1?rss=1,https://bit.ly/3LqI1xt
BioRxiv,Adaptation-proof SARS-CoV-2 vaccine design,https://biorxiv.org/cgi/content/short/2022.05.17.492310v1?rss=1,https://bit.ly/3MrwTl3
BioRxiv,SARS-CoV-2 ORF1abA1061S potentiate autoreactive T cell responses via epitope mimicry: an explanation to hepatitis of unknown cause,https://biorxiv.org/cgi/content/short/2022.05.16.491922v1?rss=1,https://bit.ly/38A3C9i
BioRxiv,Molecular analysis of a public cross-neutralizing antibody response to SARS-CoV-2,https://biorxiv.org/cgi/content/short/2022.05.17.492220v1?rss=1,https://bit.ly/3G5BhnB
